BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 4, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 8, 2007
View Archived Issues
Valeant's Xyrem launched in Canada for narcoleptics with cataplexy
Read More
Lilly receives approval in Japan for Cialis for erectile dysfunction
Read More
Paget's disease indication submitted for risedronate sodium hydrate as orphan drug
Read More
Cognitive data reported from EPOLYM trial of epoetin alfa
Read More
Genentech completes acquisition of Tanox
Read More
Gruenenthal claims new analgesic drugs in recent patent literature
Read More
Recent patents claim new compounds for the treatment of infectious diseases
Read More
New treatment options for psychological disorders described in recent patents
Read More
CeNeS grants rights to Ono for new intravenous anesthetic in Japan
Read More
Deforolimus new nonproprietary name for Ariad's AP-23573
Read More
TURNS network evaluating two different treatments for cognitive impairment in schizophrenia
Read More
Kosan enrolls patients in phase II/III trial of Hsp90 inhibitor tanespimycin
Read More
Depot formulation of olanzapine provides therapeutic D2 receptor occupancy
Read More
Promising results from phase II study of Iomai's patch-based ETEC E. coli vaccine
Read More
Phase III studies show Vidaza significantly increases survival in MDS
Read More
Novel inhibitors of HIV-1 protease dimerization described
Read More
ImmunoGen begins phase II trial of huC242-DM4 for gastric cancer
Read More
Regeneron and Bayer begin phase III study of VEGF Trap-Eye for wet AMD
Read More
PF-04548043 enters phase I for GERD
Read More
Array to initiate phase I trial of ErbB-2 inhibitor ARRY-380 for cancer
Read More
Phase II trial of Antisoma's AS-1411 in AML begins
Read More
Hana Biosciences begins phase II trial of Marqibo for ALL
Read More
Innovive reaches SPA agreement with FDA for pivotal phase II trial of tamibarotene
Read More
First approval for Pfizer's novel HIV treatment
Read More
NVA-237 progressing through clinical trials for COPD
Read More
North American clinical evaluation of GSK prepandemic H5N1 vaccine commences
Read More
FDA will review sBLA for Orencia in juvenile arthritis
Read More
Lux Biosciences' LX-211 granted fast track designation for the treatment of uveitis
Read More